Vaccine Against Hepatitis B DNA Recombinant

Recombinant DNA vaccine against hepatitis B: features and application

Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV). It can lead to various complications such as cirrhosis and liver cancer and cause death. Vaccination is one of the most effective ways to prevent hepatitis B. Recombinant DNA hepatitis B vaccine is one type of vaccine used to combat this disease.

Manufacturers of the recombinant DNA hepatitis B vaccine - Virion (Russia) and Ever Biotech (Cuba) - produce it in the form of a powder for the preparation of an injection solution or suspension for injection at a concentration of 20 μg/ml. The vaccine contains a genetically modified hepatitis B virus that does not cause disease but can activate the immune system to produce antibodies against the real hepatitis B virus.

Hepatitis B DNA recombinant vaccine has the international name “hepatitis B vaccine” and is also known under various synonyms, such as “hepatitis B vaccine recombinant yeast liquid”, “hepatitis B vaccine recombinant yeast dry”, “Shanvak-B” and “Engerix” IN".

Vaccination against hepatitis B with recombinant DNA is carried out in several stages. In the first stage, the patient is given the first dose of the vaccine, then a month after that - the second dose, and after 6 months - the third dose. This vaccine schedule provides the best protection against hepatitis B.

Hepatitis B DNA recombinant vaccine is a safe and effective vaccine. It can be used both to prevent hepatitis B and to treat people who have already become infected with the hepatitis B virus. However, like any other medical procedure, vaccination may have side effects, such as mild pain at the injection site, fever or headache. In most cases, these effects are short-lived and go away without treatment.

Hepatitis B DNA recombinant vaccine is one of the most effective and safe vaccines for the prevention of hepatitis B. It can be recommended for both children and adults, especially for those who have an increased risk of contracting hepatitis B, such as healthcare workers, patients on hemodialysis, people who use drugs, and those who have sex with infected people.

In addition, the recombinant DNA hepatitis B vaccine can be used to treat those who have already been infected with the hepatitis B virus. In such cases, the vaccine helps the immune system fight the infection and limits the development of complications.

Hepatitis B DNA recombinant vaccine is one of the most effective and safe vaccines that can prevent hepatitis B and reduce the risk of its complications. It is recommended that you consult with your doctor to determine whether hepatitis B vaccination is necessary and what doses of vaccine should be given based on the patient's age and medical history.